Bullous pemphigoid is an autoimmune subepithelial disease characterised by pruritus
followed by urticarial plaques and finally bullae on the skin and mucosa. Drug-associated …

The coexistence of psoriasis with autoimmune bullous diseases (AIBDs), particularly bullous
pemphigoid (BP), has been documented in case reports and series, as well as in …

Psoriasis in an immune-mediated inflammatory disease and is associated with increased
risk of various comorbidities, especially autoimmune bullous diseases. However, the optimal …

Highlights•Conventional immunosuppressive therapies in pemphigoid are associated with
increased morbidity and mortality.•Doxycycline has the potential of a suitable first line …

Since the concurrence of bullous pemphigoid (BP) and psoriasis was first reported in 1929,
an increasing number of studies has been published to analyse their relationship in recent …

Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies
(auto-ab) to BP180 and BP230 which affects elderly patients, predominately. Although it is a …

Objective This study aimed to investigate the clinical features of biologics-induced bullous
pemphigoid (BP) and the therapeutic effects of those agents for BP, exploring the underlying …

Introduction Several therapies for psoriasis have been described as triggers of biologic-
induced bullous pemphigoid (BIBP). The real incidence of BIBP in psoriatic patients is still …

Bullous pemphigoid is one of the most common autoimmune bullous diseases occurring
primarily in the elderly. Pathogenic autoantibodies against BP180 and BP230 at the dermal …

Bullous pemphigoid (BP) is a rare, chronic antibody-mediated autoimmune blistering
disease primarily affecting the elderly, with an age of onset over 60. Current treatment …